Currently, other methods, such as blood tests, analysis of known AD markers in cerebrospinal fluid (CSF) (Aβ and tau), positron emission tomography (PET), computed tomography (CT), or magnetic resonance imaging (MRI) scans, and cognitive tests, are performed to rule out other possibilities and point to the diagnosis.5, 6. The gene discussed is MAPT; the disease is Alzheimer disease.